Trademark: 86982214
Word
VIUM
Status
Dead
Status Code
710
Status Date
Friday, December 15, 2023
Serial Number
86982214
Registration Number
5215140
Registration Date
Tuesday, May 30, 2017
Mark Type
4000
Filing Date
Tuesday, February 9, 2016
Published for Opposition
Tuesday, August 9, 2016
Cancellation Date
Friday, December 15, 2023

Trademark Owner History
RECURSION PHARMACEUTICALS, INC. -
VIUM, INC. - Original Registrant
Mousera, Inc. - Owner At Publication

Classifications
44 Laboratory animal breeding and preconditioning; genetic testing of animals; consulting services in the field of laboratory animal caretaking; surgical services; collection, organization, analysis, and reporting of medical data in connection with non-clinical trials and studies on pharmaceuticals
42 Laboratory analysis in the field of genotyping and phenotyping of animals, laboratory animal scientific research and testing; Laboratory research in the field of genotyping and phenotyping of animals; Scientific laboratory services; Scientific research and development; Scientific research consulting in the field of genotyping and phenotyping of animals; laboratory animal scientific research and testing; research and development of pharmaceuticals and biologics; scientific testing of pharmaceuticals and biologics; biopharmaceutical research design and scientific testing services; product safety testing for pharmaceuticals, biopharmaceuticals, and biologics; toxicological safety testing services for pharmaceuticals; animal medical research and testing services for the purpose of medical research; research and development of pharmaceuticals, biotechnology, and biochemicals; platform as a service (PAAS) featuring computer software platforms for conducting preclinical research in the field of animal scientific research and testing and development of pharmaceuticals; medical and scientific research, namely, designing, organizing, conducting, monitoring, and managing non-clinical trials and studies on pharmaceuticals for others; scientific consulting services for others in the field of non-clinical trials and studies on pharmaceuticals; collection, calibration, analysis and reporting of medical and scientific research data in connection with non-clinical trials and studies on pharmaceuticals; scientific research and analysis in the fields of bioinformatics, biomarkers and phenotyping; computer hardware and software design; development, updating and maintenance of software and databases; design and development of software for use in conducting animal and biological research in non-clinical pharmaceutical development studies; providing online computer databases in the fields of research and development of pharmaceuticals, biotechnology, and biochemicals; data mining; providing a website featuring technology enabling users to remotely track, monitor, analyze, and generate reports with information and statistics from non-clinical trials and studies on pharmaceuticals; scientific research and analysis in the field of pharmacology; advisory services in the field of pharmaceutical drug development, namely, selecting animal and biological research models for use in testing drugs; advisory services in the field of pharmaceutical drug development, namely, selecting biomarkers for use in testing drugs; lead candidate drug optimization services, namely, scientific research in the field of identifying compounds for drug development; providing medical and scientific information in the fields of biochemistry, pharmaceuticals; providing online non-downloadable software for designing, conducting, analyzing, and reporting animal studies

Trademark Events
Dec 15, 2023
Cancelled Sec. 8 (6-Yr)
May 30, 2022
Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed
Aug 19, 2020
Automatic Update Of Assignment Of Ownership
Aug 6, 2020
Teas Change Of Correspondence Received
Aug 6, 2020
Attorney/Dom.Rep.Revoked And/Or Appointed
Aug 6, 2020
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Apr 11, 2019
Review Of Correspondence Complete - Power Of Attorney Entered
Apr 11, 2019
Teas Withdrawal Of Attorney Received-Firm Retains
May 30, 2017
Registered-Principal Register
Apr 22, 2017
Notice Of Acceptance Of Statement Of Use E-Mailed
Apr 21, 2017
Allowed Principal Register - Sou Accepted
Apr 21, 2017
Notice Of Approval Of Extension Request E-Mailed
Apr 20, 2017
Statement Of Use Processing Complete
Mar 30, 2017
Use Amendment Filed
Apr 20, 2017
Divisional Processing Complete
Mar 30, 2017
Divisional Request Received
Apr 20, 2017
Sou Extension 1 Granted
Mar 30, 2017
Sou Extension 1 Filed
Apr 20, 2017
Case Assigned To Intent To Use Paralegal
Mar 30, 2017
Teas Request To Divide Received
Mar 30, 2017
Sou Teas Extension Received
Mar 30, 2017
Teas Statement Of Use Received
Oct 4, 2016
Noa E-Mailed - Sou Required From Applicant
Aug 10, 2016
Automatic Update Of Assignment Of Ownership
Aug 9, 2016
Official Gazette Publication Confirmation E-Mailed
Aug 9, 2016
Published For Opposition
Jul 20, 2016
Notification Of Notice Of Publication E-Mailed
Jul 5, 2016
Law Office Publication Review Completed
Jun 26, 2016
Approved For Pub - Principal Register
Jun 23, 2016
Teas/Email Correspondence Entered
Jun 23, 2016
Correspondence Received In Law Office
Jun 22, 2016
Assigned To Lie
Jun 15, 2016
Teas Response To Office Action Received
Jun 2, 2016
Notification Of Non-Final Action E-Mailed
Jun 2, 2016
Non-Final Action E-Mailed
Jun 2, 2016
Non-Final Action Written
May 25, 2016
Assigned To Examiner
Feb 12, 2016
New Application Office Supplied Data Entered
Feb 12, 2016
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24